Relapse of depression during pregnancy following antidepressant discontinuation: A preliminary prospective study

被引：53

作者：

Cohen L.S. ^{[1
,4
]}

Nonacs R.M. ^{[1
]}

Bailey J.W. ^{[1
]}

Viguera A.C. ^{[1
]}

Reminick A.M. ^{[1
]}

Altshuler L.L. ^{[3
]}

Stowe Z.N. ^{[2
]}

Faraone S.V. ^{[1
]}

机构：

[1] Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA

[2] Pregnancy/Postpartum Mood Disord. P., Dept. of Psychiat. and Behav. Sci., Emory University School of Medicine, Atlanta, GA

[3] Mood Disorders Research Program, University of California, Los Angeles, CA

[4] Perinatal/Repro. Psych. Clin. R. P., Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114

来源：

Archives of Women’s Mental Health | 2004年 / 7卷 / 4期

关键词：

Antidepressants; Depression; Medication; Pregnancy; Relapse;

D O I：

10.1007/s00737-004-0059-3

中图分类号：

学科分类号：

摘要：

Objective: Pregnancy has frequently been referred to as a time of emotional well-being for patients. However, systematic data about the risk for relapse of depression during pregnancy are sparse. Method: We completed a longitudinal cohort study of thirty-two (N = 32) women with histories of depression who were euthymic at conception and who either discontinued or attempted to discontinue antidepressant therapy proximate to conception. Subjects were prospectively followed across pregnancy once per trimester using structured clinical interviews. Rates of relapse and time to relapse were examined. Factors distinguishing the population with respect to risk for relapse including demographic characteristics and illness history were also examined. Results: Seventy-five percent (N = 24) of patients relapsed during pregnancy. The majority of relapses (79%, N = 19) occurred in the first trimester, and relapse was more prevalent in women with histories of more chronic depression. Conclusions: Pregnancy is not protective" with respect to risk for relapse of depression. Careful treatment planning is necessary for those women on antidepressants who plan to conceive or who become pregnant."

引用

页码：217 / 221

页数：4

共 18 条

[1]

Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J., An inventory for measuring depression, Arch Gen Psychiatry, 4, pp. 561-571, (1961)

[2]

Cohen L.S., Heller V.L., Rosenbaum J.F., Treatment guidelines for psychotropic drug use in pregnancy, Psychosomatics, 30, pp. 25-33, (1989)

[3]

Cohen L.S., Rosenbaum J.F., Psychotropic drug use during pregnancy: Weighing the risks, J Clin Psychiatry, 59, SUPPL. 2, pp. 18-28, (1998)

[4]

Cohen L.S., Nonacs R., Viguera A.C., Reminick A.M., Diagnosis and treatment of depression during pregnancy, CNS Spectr, 9, pp. 209-216, (2004)

[5]

Cohen L.S., Altshuler L.L., Stowe Z.N., Faraone S.V., Reintroduction of antidepressant therapy across pregnancy in women who previously discontinued treatment: A preliminary retrospective study, Psychother Psychosom, 73, 4, pp. 255-258, (2004)

[6]

Evans J., Heron J., Francomb H., Oke S., Golding J., Cohort study of depressed mood during pregnancy and after childbirth, Br Med J, 323, pp. 257-260, (2001)

[7]

Guys W., ECDEU Assessment Manual for Psychopharmacology, Revised, (1976)

[8]

Hamilton M., A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, pp. 56-62, (1960)

[9]

Kendell R.E., Chalmers J.C., Platz C., Epidemiology of puerperal psychoses, Br J Psychiatry, 150, pp. 662-673, (1987)

[10]

Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B., Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence, J Affect Disord, 29, pp. 85-96, (1993)

← 1 2 →